Johnson & Johnson
JNJ
•Stock Analysis$152.41
+0.00 (+0.00%)• Live
Johnson & Johnson Analysis Dashboard - Stock Analysis and Financial Metrics
Historical Prices
for Johnson & Johnson
Key Financial Metrics
for Johnson & Johnson
P/E Ratio
17.13
Revenue Growth
+4.30%
EPS Growth
-57.93%
Market Cap
$373.57B
Dividend Yield
+3.23%
Debt/Equity
0.67
ROIC
+12.01%
FCF Yield
+4.97%
View additional metrics
Valuation
P/B Ratio4.78
EV/Sales4.34
Financial Health
Current Ratio1.26
Return on Assets+19.40%
Analyst Recommendations
for Johnson & Johnson
37 analysts
Consensus: Hold
About
for Johnson & Johnson
Company Details
for Johnson & Johnson
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Joaquin Duato
Employees
138,100
Market Cap
366.71B
Exchange
New York Stock Exchange
IPO Date
January 2, 1943
Website
www.jnj.comCIK
0000200406
ISIN
US4781601046
CUSIP
478160104
Country
US
Balance Sheet
for Johnson & Johnson
Cash Flow Statement
for Johnson & Johnson
Income Statement
for Johnson & Johnson
News
No news available at the moment.